{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:00:07Z","timestamp":1777554007692,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/tpj.2010.82","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T11:02:21Z","timestamp":1289905341000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice"],"prefix":"10.1038","volume":"12","author":[{"given":"J J","family":"Crowley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E J","family":"van den Oord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S S","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K C","family":"Wilhelmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T B","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Bogue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H L","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P F","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"BFtpj201082_CR1","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1101\/gr.090241.108","volume":"19","author":"AH Harrill","year":"2009","unstructured":"Harrill AH, Watkins PB, Su S, Ross PK, Harbourt DE, Stylianou IM et al. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res 2009; 19: 1507\u20131515.","journal-title":"Genome Res"},{"key":"BFtpj201082_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nmeth.1359","volume":"6","author":"H Yang","year":"2009","unstructured":"Yang H, Ding Y, Hutchins LN, Szatkiewicz J, Bell TA, Paigen BJ et al. A customized and versatile high-density genotyping array for the mouse. Nat Methods 2009; 6: 663\u2013666.","journal-title":"Nat Methods"},{"issue":"Suppl","key":"BFtpj201082_CR3","first-page":"12","volume":"31","author":"GM Simpson","year":"1970","unstructured":"Simpson GM . Long-acting, antipsychotic agents and extrapyramidal side effects. Dis Nerv Syst 1970; 31 (Suppl): 12\u201314.","journal-title":"Dis Nerv Syst"},{"key":"BFtpj201082_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1517\/14656566.9.9.1451","volume":"9","author":"P Dayalu","year":"2008","unstructured":"Dayalu P, Chou KL . Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother 2008; 9: 1451\u20131462.","journal-title":"Expert Opin Pharmacother"},{"key":"BFtpj201082_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-2007-971169","volume":"27","author":"K Soares-Weiser","year":"2007","unstructured":"Soares-Weiser K, Fernandez HH . Tardive dyskinesia. Semin Neurol 2007; 27: 159\u2013169.","journal-title":"Semin Neurol"},{"issue":"Suppl","key":"BFtpj201082_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1176\/ajp.124.8S.40","volume":"124","author":"GE Crane","year":"1968","unstructured":"Crane GE . Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am J Psychiatry 1968; 124 (Suppl): 40\u201348.","journal-title":"Am J Psychiatry"},{"key":"BFtpj201082_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.schres.2006.01.010","volume":"83","author":"PR Bakker","year":"2006","unstructured":"Bakker PR, van Harten PN, van Os J . Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis. Schizophr Res 2006; 83: 185\u2013192.","journal-title":"Schizophr Res"},{"key":"BFtpj201082_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0893-133X(98)00114-6","volume":"21","author":"VS Basile","year":"1999","unstructured":"Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA et al. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 1999; 21: 17\u201327.","journal-title":"Neuropsychopharmacology"},{"key":"BFtpj201082_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.mp.4000847","volume":"6","author":"VS Basile","year":"2001","unstructured":"Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG et al. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia. Mol Psychiatry 2001; 6: 230\u2013234.","journal-title":"Mol Psychiatry"},{"key":"BFtpj201082_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/01.jcp.0000177546.34799.af","volume":"25","author":"J de Leon","year":"2005","unstructured":"de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ . Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol 2005; 25: 448\u2013456.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtpj201082_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8","volume":"96","author":"P Eichhammer","year":"2000","unstructured":"Eichhammer P, Albus M, Borrmann-Hassenbach M, Schoeler A, Putzhammer A, Frick U et al. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen\u2032s study on DRD3 and tardive dyskinesia. Am J Med Genet 2000; 96: 187\u2013191.","journal-title":"Am J Med Genet"},{"key":"BFtpj201082_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/01213011-200503000-00003","volume":"15","author":"NA Patsopoulos","year":"2005","unstructured":"Patsopoulos NA, Ntzani EE, Zintzaras E, Ioannidis JP . CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis. Pharmacogenet Genomics 2005; 15: 151\u2013158.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201082_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone P, Remington G, Nobrega JN . The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy? Neurosci Biobehav Rev 2002; 26: 361\u2013380.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtpj201082_CR14","first-page":"2265","volume-title":"Comprehensive Textbook of Psychiatry","author":"E Hsin-Tung","year":"2000","unstructured":"Hsin-Tung E, Simpson G . Medication-induced movement disorders. In: Kaplan HI, Sadock BJ (eds). Comprehensive Textbook of Psychiatry. Lippincott Williams and Wilkins: Philadephia, PA, 2000, pp 2265\u20132270."},{"key":"BFtpj201082_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0022-5347(05)64637-X","volume":"168","author":"N Fleischmann","year":"2002","unstructured":"Fleischmann N, Christ G, Sclafani T, Melman A . The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol 2002; 168: 1265\u20131268.","journal-title":"J Urol"},{"key":"BFtpj201082_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0014-2999(01)00908-6","volume":"418","author":"K Tomiyama","year":"2001","unstructured":"Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Koshikawa N, Waddington JL . Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation. Eur J Pharmacol 2001; 418: 47\u201354.","journal-title":"Eur J Pharmacol"},{"key":"BFtpj201082_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","volume":"9","author":"JN Crawley","year":"1985","unstructured":"Crawley JN . Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 1985; 9: 37\u201344.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtpj201082_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0091-3057(90)90094-X","volume":"36","author":"DE Barnes","year":"1990","unstructured":"Barnes DE, Robinson B, Csernansky JG, Bellows EP . Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants. Pharmacol Biochem Behav 1990; 36: 883\u2013887.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFtpj201082_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","volume":"61","author":"R Gueorguieva","year":"2004","unstructured":"Gueorguieva R, Krystal JH . Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310\u2013317.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtpj201082_CR20","volume-title":"Variance Components","author":"H Goldstein","year":"1995","unstructured":"Goldstein H . Multilevel statistical models. In: Searle S, Casella G, McCulloch C (eds) Variance Components. Wiley: New York, 1995."},{"key":"BFtpj201082_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02289343","volume":"34","author":"K Joreskog","year":"1969","unstructured":"Joreskog K . A general approach to confirmatory maximum likelihood factor analysis. Psychometrika 1969; 34: 183\u2013202.","journal-title":"Psychometrika"},{"key":"BFtpj201082_CR22","volume-title":"Traditional Latent Variable Modeling Using Mplus","author":"B Muth\u00e9n","year":"2003","unstructured":"Muth\u00e9n B, Muth\u00e9n L . Traditional Latent Variable Modeling Using Mplus. Mplus Short Course Notes: Los Angeles, CA, 2003."},{"key":"BFtpj201082_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/00131640121971518","volume":"51","author":"J Van Prooijen","year":"2001","unstructured":"Van Prooijen J, Van Der Kloot WA . Confirmatory analysis of exploratively obtained factor structures. Educ Psychol Meas 2001; 51: 777\u2013792.","journal-title":"Educ Psychol Meas"},{"key":"BFtpj201082_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1601-183X.2008.00415.x","volume":"7","author":"JS Baile","year":"2008","unstructured":"Baile JS, Grabowski-Boas L, Steff BM, Wiltshire T, Churchil GA, Tarantino LM . Identification of quantitative trait loci for locomotor activation and anxiety using closely related inbred strains. Genes Brain Behav 2008; 7: 761\u2013769.","journal-title":"Genes Brain Behav"},{"key":"BFtpj201082_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1601-183X.2008.00435.x","volume":"8","author":"MJ Kas","year":"2009","unstructured":"Kas MJ, de Mooij-van Malsen JG, de Krom M, van Gassen KL, van Lith HA, Olivier B et al. High-resolution genetic mapping of mammalian motor activity levels in mice. Genes Brain Behav 2009; 8: 13\u201322.","journal-title":"Genes Brain Behav"},{"key":"BFtpj201082_CR26","volume-title":"Introduction to Classical and Modern Test Theory","author":"L Crocker","year":"1986","unstructured":"Crocker L, Algina J . Introduction to Classical and Modern Test Theory. Wadsworth Publishing: New York, 1986."},{"key":"BFtpj201082_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1124\/jpet.102.046987","volume":"305","author":"S Kapur","year":"2003","unstructured":"Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN . Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 2003; 305: 625\u2013631.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtpj201082_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209\u20131223.","journal-title":"N Engl J Med"},{"key":"BFtpj201082_CR29","first-page":"486","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler NR, Kane JM . Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982; 39: 486\u2013487.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtpj201082_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.schres.2005.07.034","volume":"80","author":"D Miller","year":"2005","unstructured":"Miller D, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH et al. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophr Res 2005; 80: 33\u201343.","journal-title":"Schizophr Res"},{"key":"BFtpj201082_CR31","volume-title":"ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW Publication No. ADM 534-537)","author":"W Guy","year":"1976","unstructured":"Guy W . ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW Publication No. ADM 534-537). US Department of Health, Education, and Welfare: Bethesda, MD, 1976."},{"key":"BFtpj201082_CR32","first-page":"53","volume":"33","author":"K Tracy","year":"1997","unstructured":"Tracy K, Adler LA, Rotrosen J, Edson R, Lavori P . Interrater reliability issues in multicenter trials, Part I: Theoretical concepts and operational procedures used in Department of Veterans Affairs Cooperative Study #394. Psychopharmacol Bull 1997; 33: 53\u201357.","journal-title":"Psychopharmacol Bull"},{"key":"BFtpj201082_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TR Barnes","year":"1989","unstructured":"Barnes TR . A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672\u2013676.","journal-title":"Br J Psychiatry"},{"key":"BFtpj201082_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.b.30777","volume":"150B","author":"KK Chadman","year":"2009","unstructured":"Chadman KK, Yang M, Crawley JN . Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 1\u201311.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201082","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:30:35Z","timestamp":1647945035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFtpj201082"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2010.82","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]},"assertion":[{"value":"4 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Sullivan reports receiving unrestricted research funding from Eli Lilly for genetic research in schizophrenia. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}